|
STX3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.550000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.517600E-02 |
| Normal-vs-Stage2 |
6.827800E-01 |
| Normal-vs-Stage3 |
2.841200E-01 |
| Normal-vs-Stage4 |
4.517600E-01 |
| Stage1-vs-Stage2 |
2.087000E-01 |
| Stage1-vs-Stage3 |
4.409200E-04 |
| Stage1-vs-Stage4 |
6.635900E-03 |
| Stage2-vs-Stage3 |
1.823440E-01 |
| Stage2-vs-Stage4 |
3.255800E-01 |
| Stage3-vs-Stage4 |
8.460800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.116600E-01 |
| Normal-vs-AfricanAmerican |
1.169950E-01 |
| Normal-vs-Asian |
3.872400E-01 |
| Caucasian-vs-AfricanAmerican |
1.369840E-01 |
| Caucasian-vs-Asian |
2.456400E-01 |
| AfricanAmerican-vs-Asian |
9.686400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.124800E-01 |
| Normal-vs-Female |
7.237300E-04 |
| Male-vs-Female |
7.3692000002179E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.244000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.545840E-01 |
| Normal-vs-Age(61-80Yrs) |
6.705600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.995800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.070200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.906000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.489400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.610200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.151400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.204600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.078360E-01 |
| Normal-vs-Grade 2 |
5.881500E-02 |
| Normal-vs-Grade 3 |
4.973200E-01 |
| Normal-vs-Grade 4 |
4.376100E-03 |
| Grade 1-vs-Grade 2 |
1.821240E-01 |
| Grade 1-vs-Grade 3 |
1.324160E-01 |
| Grade 1-vs-Grade 4 |
3.949900E-02 |
| Grade 2-vs-Grade 3 |
2.249800E-01 |
| Grade 2-vs-Grade 4 |
9.25559999975789E-07 |
| Grade 3-vs-Grade 4 |
3.818000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.91010000003289E-06 |
| Normal-vs-ccB subtype |
3.942400E-02 |
| ccA subtype-vs-ccB subtype |
5.26699794889396E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.228430E-01 |
| Normal-vs-N1 |
1.492110E-02 |
| N0-vs-N1 |
4.797400E-04 |
|
|
